Scienture Holdings, Inc.
SCNX
NASDAQ·Healthcare·Medical - Pharmaceuticals·Mkt cap $15.2M
$0.37
▲ +0.87%
P/E
-2.49
Mkt Cap
$15.2M
52-Wk Range
$0.24–$2.60
52-Week Range
$0.24 - $2.60
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 58.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Very high volatility (beta 4.0). Expect 3x market swings. Position size accordingly.
Growth
Stable outlook
Value
Deep value opportunity - significant discount to sector peers
Momentum
Stable
+3.6% over 3m
Quality
Stable
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying SCNX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 12, 2026
AUG 13, 2026
Reported EPS of -$0.07 vs -$0.09 consensus (+22.2% surprise). Revenue of $343.6K vs $2.0M expected (-82.5%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+22.2%
Revenue trend · last 2Q
—
—
Q1 26
Q2 26
$56.3M
$343.6M
Margins · last 2Q
Gross
97.7%
Profit
-821.3%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How SCNX stacks vs Medical - Pharmaceuticals
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.